Trial intelligence / Profile preview

Keppra XR in refractory epilepsy

NCT00368069Phase 3Completed

Sponsor
UCB
Start
Aug 2006
Primary completion
May 2007
Modality
Small Molecules
Countries
7
01

Overview

A Phase 3 trial of levetiracetam in epilepsy, sponsored by UCB. Started Aug 2006; status: completed.

02

Drugs

levetiracetam
03

Conditions

epilepsy

Beyond the preview

Go deeper on NCT00368069.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00368069.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call